Align Technology (ALGN) | Stock Overview & Key Data
Align Technology Performance Comparison
Stock Range
Today's Range
Low: $141.10
High: $150.22
on August 22, 2025
52 Week Range
Low: $127.70
High: $262.87
on July 31, 2025
on September 18, 2024
All-Time High: $737.45 on September 20, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$10.8B
EPS
5.92
P/E Ratio (TTM)
25.27
Forward P/E
14.58
P/B Ratio
2.77
PEG Ratio
0.73
Div. Yield
N/A
ROE
11.41%
Beta
1.611
Debt to Equity
3.14
Financial Highlights
Profitability
Gross Margin
69.94%
Operating Margin
16.10%
Profit Margin
11.04%
Returns and Earnings
Return on Assets (TTM)
6.50%
Return on Equity (TTM)
11.41%
EBITDA
$830.6M
Net Income (TTM)
$437.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$53.69
Quarterly Revenue Growth (YoY)
-1.60%
Quarterly Earnings Growth (YoY)
29.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Align Technology ALGN | 10.84B Large-cap | 5.01% | -22.93% | -13.35% | -21.58% | -28.26% | -36.07% | -40.75% | -50.24% |
| Intuitive Surgical ISRG | 168.44B Large-cap | -0.85% | -6.82% | -12.26% | -19.43% | -9.13% | -2.14% | 125.57% | 96.48% |
| Becton, Dickinson BDX | 56.36B Large-cap | 1.90% | 10.14% | 15.87% | -13.31% | -11.85% | -15.53% | -21.31% | -15.71% |
| Alcon ALC | 45.84B Large-cap | -6.49% | -7.49% | -4.78% | -8.15% | -1.71% | -14.64% | 22.89% | 42.27% |
| ResMed RMD | 42.22B Large-cap | 3.10% | 9.85% | 19.65% | 27.90% | 28.56% | 29.60% | 32.82% | 62.98% |
| West Pharmaceutical WST | 17.82B Large-cap | 0.67% | 13.23% | 18.88% | 12.11% | -24.53% | -18.14% | -18.41% | -8.74% |
Ownership & Short Interest
Insider Ownership
6.69%
Institutional Ownership
94.72%
Shares Short
3M
Short Ratio
1.83
Short % of Shares Outstanding
4.90%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Align Technology Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Align Technology would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALGN's 52-week high and low?
- In the last 52 weeks, Align Technology reached a high of $262.87 (on September 18, 2024) and a low of $127.70 (on July 31, 2025).
- What is the market cap and P/E ratio for ALGN?
- Curious about Align Technology's size and valuation? Its market capitalization stands at 10.84B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.27, and the forward P/E (looking ahead) is 14.58.
- Does ALGN pay dividends? If so, what's the yield?
- As for dividends, Align Technology isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Align Technology's main competitors or similar companies to consider before investing?
When looking at Align Technology, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG168.44B Healthcare Medical Instruments & Supplies -2.14% 125.57% Becton, Dickinson
BDX56.36B Healthcare Medical Instruments & Supplies -15.53% -21.31% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -14.64% 22.89% ResMed
RMD42.22B Healthcare Medical Instruments & Supplies 29.60% 32.82% West Pharmaceutical
WST17.82B Healthcare Medical Instruments & Supplies -18.14% -18.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Align Technology Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Align Technology's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.41%, the Debt to Equity ratio from the most recent quarter is 3.14, and its Gross Profit Margin stands at 69.94%.
- What is the recent revenue and earnings growth for ALGN?
- Looking at Align Technology's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.60%, and quarterly earnings saw a YoY growth of 29.00%.
- How much of ALGN stock is held by insiders and institutions?
- Wondering who owns Align Technology stock? Company insiders (like executives and directors) hold about 6.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 94.72%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.